Activatable anti-PDL1 antibodies, and methods of use thereof

• 收藏
• 分享

专利权人:

Inc.;CytomX Therapeutics

发明人:

Humphrey, Rachel,Carman, Lori,Will, Matthias,Zheng, Beiyao,Balinski, Kathe

申请号：

AU2018278327

公开号：

AU2018278327A1

申请日:

2018.05.31

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The invention relates generally to activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/